When French Research Sheds Light on the Vital Mechanisms of Coagulation – Cécile Denis Awarded the 2025 Jean-Paul Binet Prize
Stanislas Conseiller, Philanthropy and Fundraising Development Officer at the Paris-Saclay School of Medicine, shared on LinkedIn:
“When French research sheds light on the vital mechanisms of coagulation and paves the way for new therapies!
Congratulations to Cécile Denis on receiving the 2025 Jean-Paul Binet Prize
Awarded by the French Medical Research Foundation, it is a well-deserved distinction for his work at the head of the Haemostasis, Inflammation, Thrombosis Unit.
Understanding coagulation to transform the management of vascular diseases.
His team deciphers the essential mechanisms of the coagulation cascade, in particular the role of von Willebrand factor (VWF). Their work has highlighted still little-known interactions between these blood components and the vascular wall, revealing:
– the central role of the VWF in pathologies such as strokes, where thrombosis and inflammation are intimately linked,
– the unexpected involvement of VWF in the survival of cancer cells.
These fundamental advances pave the way for new diagnostic and therapeutic strategies for complex vascular or hemorrhagic diseases, which have long been difficult to treat.
I had already had the opportunity to mention one of the innovations that came out of this group: the development of a nanobody capable of stabilizing VWF and correcting coagulation in patients with von Willebrand disease, a real glimmer of hope for improving their care.
This Prize illustrates not only the scientific excellence of Cécile Denis and her team, but also the crucial importance of supporting fundamental research in hemostasis, the basis for innovative treatments for tomorrow.
Congratulations to the whole team!”
Find more posts on Hemostasis Today.
-
Feb 17, 2026, 15:32Gabrielle Sarlon: Key Messages to Improve VTE Management in Women of Childbearing Age
-
Feb 17, 2026, 15:27Piezo1 Gain-of-Function Mutation Explains Thromboembolic Complications in Hereditary Xerocytosis – JTH
-
Feb 17, 2026, 15:20Giulia Simini: MATRON Study Selected as Top-Scoring Abstract at the BSH Annual Scientific Meeting
-
Feb 17, 2026, 15:082026 NLA Clinical Consensus: Updated LDL and ApoB Targets in Familial Hypercholesterolemia
-
Feb 17, 2026, 14:56Mohamed Sikkander Abdul Razak: Three Days in Nature and Long-Lasting Immune Benefits
-
Feb 17, 2026, 14:46Bartosz Hudzik: Better Control, Similar Tolerability With Quadruple Therapy in Resistant Hypertension
-
Feb 17, 2026, 14:33Richard Keller: Efficacy and Safety of Enlicitide in High-Risk ASCVD Patients
-
Feb 17, 2026, 14:32Flora Peyvandi: Population Pharmacokinetics to Guide Tailored Surgical Dosing in Von Willebrand Disease
-
Feb 17, 2026, 13:54Wolfgang Miesbach: 43-Year Study Links Black Coffee to Reduced Dementia Risk